SPID® (Screen Printed Innovative Drug) Technology is Laxxon’s additive 3D screen-printing and manufacturing process. With our patented technology, we can produce a generation of smart drug delivery systems (DDSs) with tailored pharmacokinetics based on advanced geometric internal structures, heterogeneous distribution of active ingredients, and choice of materials.
Laxxon has both an external pipeline as well as an in-house Advanced Patented Generic pipeline. All products created with our SPID®-Technology manufacturing approach – whether engineered in-house or with an external partner – are patent protected.
Laxxon Medical owns the exclusive worldwide rights for the development, production and commercialization of innovative drug delivery systems on the basis of a worldwide patented large-scale 3D screen printing technology (SPID®-Technology).
Increased product volume
Laxxon’s 3D screen printing enables the mass-production of tablets, film, implants, and transdermal patches with novel drug formulations and galenic, through novel geometric structures for multiple API combinations.
Faster, more customized printing
The printing speed is significantly faster than any other 3D printing process. Each layer of the pill may have different dissolving speeds and layers can be as fine as 10 microns.
Clinical trials to production
Our technology can handle small batch sizes for pre-clinical/ clinical trials as well as mass production.
Our Innovative Process & Products
Laxxon’s 3D screen printing technology offers a unique combination of benefits ranging from cost advantages and size-independent production streams (same process for clinical samples or mass production) to the improvement of bioavailability and enhancement of solubility.
SPID® Improvements to Drug Delivery
Improves pharmacokinetics of active pharmaceutical ingredients, improving bioavailability and efficacy
Enhances the ability of active pharmaceutical ingredients to dissolve
Reduction of adverse side effects
Improvements to patient compliance increase success with therapies
Up to 1.5MM units per day of tablets, film, implants, transdermal patches with novel drug formulations, galenic and novel geometric structures
The cold process reduces the risk of heat-related damages to ingredients and increases the range of applicable APIs and freedom of materials
Range of APIs
Enables a wide range of APIs, including multiple API combinations in a single DDS
Printing speed is significantly faster than any other 3D printing process
Reduction of multiple daily doses to a single dose
The Possibilities of Our Technology
Information integrated into the tablets can fulfill various functions:
Providing product and safety information
Combating counterfeit medications
New ways of patient monitoring
Automated medication dispensing
One area that can particularly benefit from 3D screen printing is patient safety. The process enables the direct integration of QR codes into the surface of each individual tablet. QR codes can store relatively large amounts of information. They can be easily read anywhere using appropriate mobile digital devices.